
News

Pirfenidone combined with UC-MSCs reversed bleomycin-induced pulmonary fibrosis
Scientific Reports,, 04 August 2025 Pulmonary fibrosis (PF) is a progressive, irreversible disease with current treatment options being limited and not entirely effective. Specifically, idiopathic

Therapeutic Potential of Mesenchymal Stem Cells in Psoriasis
Cell Biochemistry and Biophysics, 01 August 2025 Introduction Psoriasis is a chronic inflammatory skin disease with a pathogenesis closely related to immune dysregulation. Its hallmark

Intravenous umbilical cord-derived mesenchymal stromal cell therapy may improve overall survival in Japanese patients with idiopathic pneumonia syndrome after hematopoietic stem cell transplantation: a multicenter, single-arm, phase II trial
International Journal of Hematology, 15 July 2025 Background Idiopathic pneumonia syndrome (IPS) is a rare but life-threatening complication following hematopoietic stem cell transplantation (HSCT), with

Future Perspectives: Implementation of Artificial Intelligence in Umbilical Cord Biobanking
Biobanking, July 9 2025 Introduction The integration and implementation of Artificial Intelligence (AI) in umbilical cord biobanking is still in its early stages. However, AI

Therapeutic potential of super activated platelet lysate (sPL) and umbilical cord mesenchymal stem cells (UCMSCs) in enhancing endometrial regeneration in rats with thin endometrium
Scientific Reports, 09 July 2025 A recent preclinical study demonstrated that the combination of super activated platelet lysate (sPL) and umbilical cord-derived mesenchymal stem cells

Clinical outcomes of allogeneic hematopoietic stem cell transplant with different stem cell sources in infant acute myeloid leukemia
Scientific Reports, 08 July 2025 Background Acute myeloid leukemia (AML) in infants is a rare hematologic malignancy characterized by distinct biological features and variable prognosis.

Dynamic changes in BDNF, VEGF, and GDNF after transplanting human protein-based scaffolds with Wharton’s Jelly MSCs in a rat brain injury model
Scientific Reports, 02 July 2025 Background Central nervous system (CNS) injuries are a major cause of permanent neurological deficits, and current therapeutic strategies remain limited.

Mechanism of umbilical cord mesenchymal stem cells in the expansion of umbilical cord blood-derived hematopoietic stem cells in vitro
Journal of International Medical Research, 24/06/2025 Introduction Umbilical cord blood is one of the most promising sources of hematopoietic stem cells (HSCs), especially important in

Umbilical Cord-Derived Mesenchymal Stem Cell Therapy: A Promising Comprehensive Approach for Type 2 Diabetes Mellitus
Dovepress, May 19 2025 A large-scale retrospective clinical study recently published in Diabetes, Metabolic Syndrome and Obesity has demonstrated the safety and therapeutic efficacy of

New stem cell therapy to treat patients with blood cancers
EMA, 20 June 2025 Zemcelpro provides an option for patients with blood cancer who need a blood stem cell transplant and have no suitable donor